Safety and Efficacy of Rifampin or Isoniazid Among People With <i>Mycobacterium tuberculosis</i> Infection and Living With Human Immunodeficiency Virus or Other Health Conditions: Post Hoc Analysis of 2 Randomized TrialsJonathon R. Campbell, Dick Menzies, Boubacar Bah et al.|Clinical Infectious Diseases|2020Cited by 27